LA-1 (Adhaere Pharmaceuticals)

N/A

Report date: 2025/03/20 16:13:08
NME

Base Information

Drug NameLA-1 (Adhaere Pharmaceuticals)
Drug Alias Nameintegrin CD11b agonists (Adhaere)LA-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-M agonists
TargetsIntegrin alpha-M
Therapy Area/IndicationsLupus Erythematosus, SystemicNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdhaere Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAdhaere Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, SystemicNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A